Have a feature idea you'd love to see implemented?
Let us know!
LFMD LifeMD Inc
Price (delayed)
$4.38
Market cap
$188.64M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.7
Enterprise value
$173.75M
LifeMD, Inc. (formerly Conversion Labs) is a leading telehealth company that is transforming the healthcare landscape with direct-to-patient product and service offerings. LifeMD's telemedicine platform enables virtual access to affordable
Highlights
LifeMD's equity has surged by 74% YoY
The gross profit has grown by 43% YoY and by 10% from the previous quarter
The quick ratio has soared by 63% YoY but it has contracted by 12% from the previous quarter
The debt is up by 36% year-on-year and by 4.6% since the previous quarter
Key stats
What are the main financial stats of LFMD
Market
Valuations
Earnings
Shares outstanding
43.07M
Market cap
$188.64M
Enterprise value
$173.75M
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
1.01
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.97
Revenue
$178.28M
EBIT
-$20.72M
EBITDA
-$12.66M
Free cash flow
$6.59M
Per share
Balance sheet
Liquidity
EPS
-$0.7
Free cash flow per share
$0.16
Book value per share
-$0.1
Revenue per share
$4.32
TBVPS
$1.18
Total assets
$63.82M
Total liabilities
$65.88M
Debt
$20.82M
Equity
-$4.21M
Working capital
-$6.58M
Debt to equity
-4.95
Current ratio
0.87
Quick ratio
0.8
Net debt/EBITDA
1.18
Margins
Efficiency
Dividend
EBITDA margin
-7.1%
Gross margin
88.9%
Net margin
-13.2%
Operating margin
-10.8%
Return on assets
-47.4%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
-170.3%
Return on sales
-11.6%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LFMD stock price
How has the LifeMD stock price performed over time
Intraday
-0.9%
1 week
-7.98%
1 month
-14.45%
1 year
-34.33%
YTD
-47.17%
QTD
-16.41%
Financial performance
How have LifeMD's revenue and profit performed over time
Revenue
$178.28M
Gross profit
$158.52M
Operating income
-$19.22M
Net income
-$23.5M
Gross margin
88.9%
Net margin
-13.2%
LFMD's operating margin is up by 50% year-on-year
The net margin is up by 43% year-on-year and by 8% since the previous quarter
The gross profit has grown by 43% YoY and by 10% from the previous quarter
The revenue has grown by 39% YoY and by 9% from the previous quarter
Growth
What is LifeMD's growth rate over time
Valuation
What is LifeMD stock price valuation
P/E
N/A
P/B
N/A
P/S
1.01
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.97
The EPS has grown by 33% YoY and by 5% from the previous quarter
LifeMD's equity has surged by 74% YoY
The P/S is 46% below the 5-year quarterly average of 1.9 and 46% below the last 4 quarters average of 1.9
The revenue has grown by 39% YoY and by 9% from the previous quarter
Efficiency
How efficient is LifeMD business performance
LFMD's ROA has soared by 54% year-on-year and by 12% since the previous quarter
The ROS has grown by 46% YoY and by 6% from the previous quarter
Dividends
What is LFMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LFMD.
Financial health
How did LifeMD financials performed over time
LifeMD's total assets is 3.1% less than its total liabilities
LifeMD's total assets has soared by 80% YoY and by 3.8% from the previous quarter
The quick ratio has soared by 63% YoY but it has contracted by 12% from the previous quarter
LFMD's debt to equity has surged by 79% since the previous quarter
LifeMD's equity has surged by 74% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.